Clinical Trials Browser

Phase EARLY_PHASE1 × OTHER × Interleukin-6 × Clear all

NCT05316116 2026-02-05

Siltuximab in Large Granular Lymphocytic Leukemia (LGLL)

Phase EARLY_PHASE1 Terminated

Other hematologic neoplasm

Leukemia, Large Granular Lymphocytic

NCT00470093 2018-11-16

Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple Myeloma

Phase EARLY_PHASE1 Terminated

3 enrolled 6 charts

Multiple Myeloma, Neoplasms, Plasma Cell